SEC Tracker
Get the app

Corcept Therapeutics CORT

Corcept Therapeutics: Officer sells shares

Joseph Douglas Lyon, insider filing for CORT

Form
4
Filed
Importance
Routine
  1. Oct 1, 2026: 810 shares sold at $115.40
  2. Oct 2, 2026: 5,833 shares bought at $19.26
  3. Oct 2, 2026: 4,744 shares sold at $116.54
  4. Reporting person is Chief Accounting & Technology Officer

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Repligen RGEN public float $6.0B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  5. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025